The redesigned accountable care organization (ACO) model is called the Realizing Equity, Access, and Community Health model and is scheduled to begin in 2023.
CMS said Thursday it is redesigning its accountable care organization (ACO) model away from its Global and Professional Direct Contracting (GPDC) model into one that focuses on health equity.
Slated to begin in 2023, the ACO Realizing Equity, Access, and Community Health (REACH) Model “addresses stakeholder feedback, participant experience, and Administration priorities, including CMS’ commitment to advancing health equity,” CMS said in a statement.
In addition, CMS is canceling the Geographic Direct Contracting Model, which was announced in December 2020 by the Trump administration but was paused in March 2021.
“The Biden-Harris Administration remains committed to promoting value-based care that improves the health care experience of people with Medicare, Medicaid and Marketplace coverage,” CMS Administrator Chiquita Brooks-LaSure said in a statement. “To fulfill that commitment, CMS, through the Innovation Center, is testing new models of health care service delivery and payment to improve the quality of care that people receive, including those in underserved communities. The Innovation Center is making improvements to existing models and launching new models to increase participation in our portfolio, and CMS will be a strong collaborator to health care providers that participate in those models.”
GPDC will continue until December 31, 2022, and then will transition to the REACH model, but for the rest of the year, CMS said it will operate GPDC "with more robust and real-time monitoring of quality and costs."
The first performance year of REACH will start on January 1, 2023, and the model performance period will run through 2026.
Earlier this month, the National Association of ACOs (NAACOS) sent a letter to HHS asking that GPDC be overhauled instead of canceled. The letter, signed by more than 200 organizations, said that ending GPDC would stall the movement to value-based care.
In a statement released Thursday, NAACOS praised CMS and said REACH was basically a continuation of GPDC, "albeit with numerous changes and a new name."
"Many of the criticisms against Direct Contracting were a product of great misunderstanding about the model and the overall shift to value-based payment," NAACOS said. "Instead, keeping the model with additional focus on equity, increased provider governance, improvements to risk adjustment, and other changes is best moving forward." CMS adopted many of the changes the organization has been lobbying for, NAACOS said.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Early Involvement Critical in Treating Immunotherapy-Induced Overlap Syndrome
April 19th 2024A series of case studies reveals the importance of early diagnosis and involvement of special teams of clinicians when dealing with potential cases of overlap syndrome, which encompasses myocarditis, myasthenia gravis, and immune checkpoint inhibitor–related myositis.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Government agencies have created an online portal for the public to report potential anticompetitive practices in health care; there are changes coming to the “boxed warning” section for chimeric antigen receptor T-cell therapies (CAR T) to highlight T-cell blood cancer risk; questions about the safety of obesity medications during pregnancy have arisen in women on them who previously struggled with fertility issues.
Read More